🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Northland starts Abacus Life shares coverage with Outperform rating

EditorNatashya Angelica
Published 10/24/2024, 09:18 PM
ABL
-

On Thursday, Northland initiated coverage on Abacus Life Inc. (NASDAQ:ABL) shares with an Outperform rating and set a price target of $13.50. Abacus Life, a prominent player in the life insurance policy purchasing sector and an alternative asset manager, has been recognized for its specialized focus on insurance products offering liquidity solutions to customers.

The firm, a member of the Life Insurance Settlements Association (LISA) and holding an A+ rating as a BBB Accredited Business, has caught the attention of Northland for its vertical integration and its role in the life insurance settlements market. The Outperform rating indicates Northland's expectation that Abacus Life's stock will perform better than the average return of the stocks analyzed by the firm.

Abacus Life's business model involves providing liquidity to policyholders by buying life insurance policies, a service that caters to a niche market within the financial services industry. The company's approach has positioned it as a key player in the life insurance settlements space, allowing policyholders to access the value of their life insurance through sales rather than waiting on claims.

The stock price target of $13.50 reflects Northland's confidence in the potential growth and profitability of Abacus Life. This target is a projection of where the stock price could go in the future, based on Northland's analysis of the company's business prospects and market position.

The coverage initiation by Northland could potentially influence investor sentiment and market perception of Abacus Life. As market participants digest this new information, the stock's performance in the upcoming trading sessions may be an area of focus for investors tracking the life insurance settlements industry.

In other recent news, Abacus Life Inc. reported robust financial results for the quarter ending June 30, 2024, exceeding previous estimates. The company invested over $100 million in the quarter, surpassing Piper Sandler's projection of $61 million. Piper Sandler has maintained its Overweight rating for Abacus Life and adjusted its core earnings per share projections upward for the coming years.

Abacus Life has also made significant strides in expanding its portfolio and assets under management (AUM) through strategic acquisitions. The company recently acquired FCF Advisors and Carlisle Management Company SCA, expected to add approximately $600 million and $2 billion to its AUM respectively.

Piper Sandler and B.Riley Securities have expressed confidence in Abacus Life's performance, with B.Riley Securities revising its price target for the company to $15.00, maintaining a Buy rating. The firms suggest that the raised capital from a recent common stock offering and assumed debt could enable Abacus Life to acquire additional policies, potentially generating significant revenue.

Abacus Life has also announced the appointment of Elena Plesco as its new Chief Capital Officer, overseeing the company's capital management strategies and global expansion efforts. These are the recent developments for Abacus Life Inc.

InvestingPro Insights

Northland's optimistic outlook on Abacus Life Inc. (NASDAQ:ABL) is complemented by several key financial metrics and insights from InvestingPro. The company's revenue growth has been impressive, with a 98.62% increase over the last twelve months as of Q2 2024, and an even more striking 155.53% growth in the most recent quarter. This robust top-line expansion aligns with Northland's positive stance on the company's prospects.

Despite the strong revenue growth, InvestingPro Tips highlight that Abacus Life has not been profitable over the last twelve months. However, analysts predict the company will turn profitable this year, which could support Northland's Outperform rating.

The stock's recent performance has been challenging, with InvestingPro data showing a 17.7% price decline over the past three months and a 26.63% drop over six months. This downturn might present an opportunity for investors who agree with Northland's bullish outlook.

InvestingPro Tips also reveal that Abacus Life's liquid assets exceed its short-term obligations, suggesting a solid financial position that could provide stability as the company pursues growth. For investors seeking more comprehensive analysis, InvestingPro offers 8 additional tips for Abacus Life, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.